Crossmark

Microwave ablation compared with hepatic resection for the treatment of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12957-019-1632-6

Published Online: 2019-06-10

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Glassberg, Mrudula B.

Ghosh, Sudip

Clymer, Jeffrey W.

Wright, George W. J.

Ferko, Nicole

Amaral, Joseph F.
Funding

Funding for this research was provided by:

Ethicon
License Information

Text and Data Mining valid from 2019-06-10

Version of Record valid from 2019-06-10
More Information

Article History

Received: 25 February 2019

Accepted: 20 May 2019

First Online: 10 June 2019

Ethics approval and consent to participate

: Not applicable

: Not applicable

: MBG, JWC, SG, and JFA are employees of Ethicon, Inc., manufacturer of the NeuWave microwave ablation system. GWJW and NCF are employees of Cornerstone Research Group, who were sponsored to perform this study by Ethicon, Inc.

Document is current

Any future updates will be listed below